Icon

GANZYK-RTU (nda209347)- (500MG/250ML (2MG/ML))

GANCICLOVIR EXELA PHARMA
500MG/250ML (2MG/ML)
No Yes
2034-Sep-02 Expired
None None
None No
GANCICLOVIR INJECTION is a nucleoside analogue CMV DNA polymerase inhibitor indicated for the: • Treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). • Prevention of CMV disease in adult transplant recipients at risk for CMV disease.
0 0 0
Total Other Developers None
Drugs with Suitability No
500MG/250ML (2MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.